BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30886205)

  • 1. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
    Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
    Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 3. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
    Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
    Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by
    Gu J; Xiao Y; Shu D; Liang X; Hu X; Xie Y; Lin D; Li H
    Dis Markers; 2019; 2019():3491852. PubMed ID: 31089393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
    Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
    J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolomics analysis for early detection of colorectal cancer.
    Uchiyama K; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Okayama T; Yoshida N; Katada K; Kamada K; Handa O; Ishikawa T; Takagi T; Konishi H; Kuriu Y; Nakanishi M; Otsuji E; Itoh Y; Naito Y
    J Gastroenterol; 2017 Jun; 52(6):677-694. PubMed ID: 27650200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
    Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
    Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on plasmatic metabolomics of Uygur patients with essential hypertension based on nuclear magnetic resonance technique.
    Zhong L; Zhang JP; Nuermaimaiti AG; Yunusi KX
    Eur Rev Med Pharmacol Sci; 2014; 18(23):3673-80. PubMed ID: 25535139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
    Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
    Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
    Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
    Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Metabolomics Study of Patients with Bicuspid Aortic Valve Disease.
    Chessa M; Panebianco M; Corbu S; Lussu M; Dessì A; Pintus R; Cesare Marincola F; Fanos V
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
    Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary metabonomic study on colorectal cancer.
    Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
    J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of faecal
    Wong SH; Kwong TNY; Chow TC; Luk AKC; Dai RZW; Nakatsu G; Lam TYT; Zhang L; Wu JCY; Chan FKL; Ng SSM; Wong MCS; Ng SC; Wu WKK; Yu J; Sung JJY
    Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-invasive fecal metabonomic detection of colorectal cancer.
    Phua LC; Chue XP; Koh PK; Cheah PY; Ho HK; Chan EC
    Cancer Biol Ther; 2014 Apr; 15(4):389-97. PubMed ID: 24424155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.